Carbon Monoxide therapy for Myocardial Infarction: Carbon Monoxide (CO) improves myocardial function after myocardial infarction via up-regulation of PNUTS, 9/November/2016, 7.14 am

Anti-telomerase cancer therapy: MiRNA-1246 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and inhibits cancer progression via down-regulation of its target gene, 8/November/2016, 10.47 pm
November 8, 2016
Natural product therapy for Breast Cancer: Luteolin, a flavonoid found in Salvia tomentosa, Perilla, thyme, among others, inhibits the proliferation of tumor-initiating cells in breast cancer, suppresses the progression of metastatic breast cancer, and supports tumor relapse-free survival in breast cancer patients, 9/November/2016, 10.08 pm
November 9, 2016
Show all

What they say: 

A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March  2013 issue of Nature  by Prof Dimmler, Boon, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Carbon Monoxide therapy for Myocardial Infarction: Carbon Monoxide (CO) improves myocardial function after myocardial infarction via  up-regulation of PNUTS


Significance:

Given that: (1)  cardiovascular disease is the leading cause of death worldwide; (2) in India, in 2004, 14.6 lakhs deaths (14% of total deaths) were due to ischemic heart disease; and (3) the global economic cost spent in the treatment of cardiovascular disease in 2011 was little more than 10 billion US dollars, there is an urgent need to find: (i)  a way to induce regeneration of adult cardiomyocytes that were lost in Myocardial patients; (ii) a cheaper alternative to the existing expensive drugs; and (iii) a side-effect-free drug.


From Research Findings to Therapeutic Opportunity: 

This study suggests a gaseous cardiac regeneration therapy. Carbon Monoxide (CO), by decreasing the expression of its target gene, it may increase the expression of PNUTS. Thereby, it may: (1) inhibit DNA damage responses, (2) inhibit telomere shortening; and (3) promote cardiomyocyte survival/regeneration.

Image result for Carbon Monoxide Therapy

Carbon Monoxide (CO) therapy promotes Cardiomyocyte survival and protects against myocardial infarction via up-regulation of PNUTS

Thus, by subjecting myocardial patients to carefully controlled Carbon Monoxide (CO) therapy, one may prevent ageing-associated (or, stress-associated) decline in cardiac function. Together, this study suggests that Carbon Monoxide (CO) therapy may be adapted to improve cardiac function after myocardial infarction.  


Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Web:http://genomediscovery.org or http://newbioideas.com

To citeBoominathan, L.,  Carbon Monoxide therapy for Myocardial Infarction: Carbon Monoxide (CO) improves myocardial function after myocardial infarction via  up-regulation of PNUTS, 9/November/2016, 7.14 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org


Undisclosed information: How   Carbon Monoxide (CO) increases the expression of PNUTS

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $300#

Results guaranteed if not refunded

# Research cooperation


Attention: Kindly understand that this idea was posted earlier by us, but then we lost it on our website because somebody had hacked our website in the second week of Oct, 2015. We are in the process of recovering our ideas posted earlier, especially from May, 2015 to October, 2015. So, this idea is re-posted for the sake of the researchers.

Comments are closed.